Aseptic Filling Process (Media Fill) Validation Protocol in Sterile Pharmaceuticals

-
1.0 OBJECTIVE
1.1  To define procedures for validating and maintaining the validation of all aseptic filling processes and qualification of the quality of the product by system/facility/equipment.
2.0  SCOPE
2.1  This procedure applies to all aseptically filled sterile products intended for human use.
3.0  RESPONSIBILITY
3.1  The Validation personnel coordinate the aseptic filling validation program and write the sterile media aseptic filling processes reports.
3.2  Manufacturing personnel the sterile media aseptic filling processes and performs the sterile media fills.
3.3  QA personnel perform the sampling and assist with the IPQA monitoring required for each sterile media fill.
3.4  QC personnel to perform the testing and assist with the monitoring required for each sterile media fill.
4.0  ACCOUNTABILITY
4.1  Manager QA
5.0  REFERENCE (S)
5.1  In- house.
5.2Pharmaceutical Inspection convention Guideline.(PIC)




6.0  Procedure
6.1  EXIT AND ENTRY PROCEDURE
6.1.1  All Operators and Supervisors enter department as per Defined Gowning procedure.
6.2  AMPOULE FILLING MEDIA
6.2.1  The media fill run shall be performed for approximately the same duration as required for filling of a normal production batch (approx. 12 hours).
6.2.2  Batch (Media) manufacturing shall be done in the initial hours of the 1st shifts, followed by other processing steps normally followed.
6.2.3  Nitrogen flushing shall not to be done during media filling.
6.2.4  The filling of media shall be done in the following sequence:-
6.2.4.1  The media (Soybean Casien Digest Madium) batch shall be manufactured in the manufacturing area. The bulk is then aseptically filtered in-to a sterile holding tank (under LAF) in the sterile area. The tank containing the filtered solution is then connected sterile silicon pipeline and filling done inampulewithout employing the use of on-line cartridge filters/filter housing on themachine.
6.2.4.2  Fill volume of media as per the protocol. (The fill volume of media in units need not equal the fill volume of finished product units, the quantity filled shall be sufficient to wet all the inner surfaces of the unit & to enable inspection to detect positives.)
6.2.4.3  Filling activity is performed in the filling room (especially the filling zone) under LAF.
6.2.4.4 Consecutive first three runwill be validatedwith sterile media solution.6.2.4.5  Simulate the adverse condition testing of the system (details of adverse conditions given separately in step 6.4) after filling approximately 10,000 units
6.2.4.6   Filling to be planned in a manner such that the operator covers the activities during the shift change over.
6.3  Vial filling media
6.3.1  The media fill run shall be performed for approximately the same duration as required for filling of a normal production batch (approx. 12 hours)
6.3.2  Batch (media) manufacturing shall be done in the initial hours of the 1st shifts, followed by other processing steps normally followed.
6.3.3  Nitrogen flushing shall not be done during media filling.
6.3.4  The filling of the media to be done in the following sequence-
6.3.4.1  The media (Soybean Casien Digest Madium) batch is manufactured in the manufacturing area. The bulk is then aseptically filtered in-to a sterile holding tank (under LAF) in the sterile area. The tank containing the filtered solution is then connected with is sterile silicon pipeline and filling done in vials without employing the use of on-line cartridge filters/filter housing on the machine and then dosing of sterilelactose in vials.
6.3.4.2  Transfer the sterile lactose through material air lock in to the sterile area and transfer the sterile lactose aseptically in to the previouslysterilizedhopper of the vial filling machine. Three run will be validated with 250 mg sterile lactose and 5 ml media solution, 500 mg sterile lactose with 5 ml media solution and 1000 mg sterile lactose with 10 ml media solution to validate the weight range from 250 mg to 1000 mg.
6.3.4.3  Fill volume of media or weight of Powder as per the protocol. (The fill volume of media filled units need not equal the fill volume of finished product units, the quantity filled shall be sufficient to wet all the inner surfaces of the unit& to enable inspection to detect positives.)
6.3.5  Filling activity is performed in the filling room (especially the filling zone) under LAF.
6.3.6  Simulate the adverse condition testing of the system (details of adverse conditions given separately in step 6.4) after filling approximately 10,000 units.
6.3.7  Filling to be planned in a manner such that the operator covers the activities during the shift change over.
6.4  ADVERSE CONDITIONS:  (AMPULE/ VIAL)
6.4.1  Filling machine OFF:For 60 minutes (The filtered air supply in the filling zone not to be put off. Imitate maintenance activities that are likely to take place during routine filling process, after restarting approx. 1,000 units to be filled)
6.4.2  LAF Filtration OFF:For 5 minutes (filling to be done when LAF is OFF)6.4.3  Air Handling Units power OFF:For 5 minutes (ALL the AHU’s of the sterile and the adjoining areas to be switched OFF, filling to be done when AHU’s are OFF).
6.4.4  Total Power OFF for 2 minutes:(ALL the AHU’s of the sterile and the adjoining areas, filling m/c, LAF’s etc to be switched OFF, after restarting approx. 1,000 units to be filled)
6.4.5  Highest (250ampule/vial min.) speed of machine:approx. 1,000 units to be filled6.4.6  Change in tubing’s:Approx. 1,000 units to be filled6.4.7Ampule/Vial Sterilizing tunnel OFF:For 5 minutes (total power supply of the tunnel is to be switched OFF, after restarting tunnel all the units from the cooling zone to be filled).
6.5  STORAGE OF FILLING UNITS (AMPULE/VIAL)6.5.1  Collect all units in tray or suitable container,Store in previously maintained temperature defined area or incubator.
6.5.2  First Store at temperature 20 -25 ° C for seven days.
6.5.3  After that Store at temperature 30 -35 ° C for seven days.6.6  RESULT1. After the incubation period of the media-filled containers they are visually examined for microbial growth. Contaminated containers should be examined for evidence of container/closure damage which might compromise the integrity of the packaging system. Damaged containers should not be included as failures (positives) when evaluating results.2. The number of containers used for media fills should be sufficient to enable a valid evaluation. For small batches, the number of containers for media fills should at least equal the size of the product batch. The target should be zero growth and the following should apply:•  When filling fewer than 5000 units, no contaminated units should be detected.•  When filling 5,000 to 10,000 units,a) One (1) contaminated unit should result in an investigation, including consideration of a repeat media fill;b) Two (2) contaminated units are considered cause for revalidation, following investigation.•  When filling more than 10,000 units:a)
One (1) contaminated unit should result in an investigation;b) 
Two (2) contaminated units are considered cause for revalidation, following investigation.Abstracted from:PIC 007-5 dated 01 July 2009Recommendation on the Validation of aseptic processes.
6.7  DESTRUCTION OF MEDIA:
6.7.1  After 14 days media shall be destruct as per sop or procedure.
6.8  FREQUENCY OF MEDIA FILLS (AMPULE/VIAL):
6.8.1  Initial Three consecutive Successful Run(allcontainer size employed for filling on the machine) before start production for qualified area or equipment.
6.8.2  Then after once in 6+1 month of Single run any suitable volume for re-qualification of area or equipment.
6.8.3  If any change or modification of critical  equipment or  area then go  for single run media for  any suitable volume  before starting production.
6.8.4  If critical equipment or area are not in use for about one month than go for single run media for  any suitable volume  before starting production.
6.8.5  As and when required.



Comments

Post a Comment

Popular posts from this blog

Requirement of Active and Passive Air Sampling in Controlled Areas

-
Air sampling is a mandatory procedure to be followed in pharmaceuticals to produce the contamination free quality product. What would you say if I ask for the causes the most contamination of products during the manufacture of pharmaceuticals? However, air is another keysource of contaminationthat most pharmaceutical facilitiesoften ignore to take precaution from. Air samplingor air monitoring is essential for Quality Control(QC) purposes especially in companies that manufacture pharmaceutical products in controlled areas or clean rooms with filtered air.Well, what pharmacists, health care practitioners, and microbiologists refer to as air sampling can simply be defined as taking a correct measurement of the practical airborne bacteria, mold, yeast, spores and fungal cells which can be collectively referred to as bioburden in the surrounding air. The two main methods used to sample air are: 1 .Active air sampling/ monitoring 2.Passive air sampling/ monitoring 1. Active Air Sampl
http://totalpharmasoloution.blogspot.in
-
What is VMP Brief information about Qualification, Validation and calibration of Equipment, Instrument and System. A document providing information on the company’s validation work programme. It should be define details of and timescales for the validation work to be performed. Responsibilities relating to the plan should be stated. 2.2 Which Guideline follow for preparation of VMP PIC/S (PI 006), WHO TRS 961, Eudralex Volume 4 2.3 Contents of VMP.  Cover Page, Table of contents  Approval of document  Introduction, Objective, Scope  Quality policy  Validation policy  Quality Risk Management Policy  Responsibility  Validation / Qualification Schematic Flow  Validation and Qualification approach  Revalidation and Requalification approach  Qualification Activity  Facility Qualification  Qualification and Validation of Utilities  Equipment Qualification  Laboratory Instruments and Equipment  Personnel Qualification  Products and Process Validation  E
http://totalpharmasoloution.blogspot.in
-
Image
Purified Water Storage and Distribution System Learn about the purified water storage and distribution system and procedure for validation. The purified water is prepared by purified water generation system (Reverse Osmosis System) and collected in purified water storage tank of required capacity and distributed by a centrifugal pump for loop recirculation.At different points of use separate heat exchangeris provided (if required) to bring down temperature of hot circulating water as and when required. There is a back pressure valve in the return line. Instruments and on/off valve are for controlling and monitoring the system  operation and water quality. These are controlled from a centralized control panel consisting of a PLC board. The distribution piping consists of sanitary tubes, fittings, valves with orbital welding and triclover clamp in manufacturing area and for instrument connections. The water through this piping is supplied to various user points and circulated back
http://totalpharmasoloution.blogspot.in